BACKGROUND: Since the 2008 inception of universal childhood influenza vaccination, national rates have risen more dramatically among younger children than older children and reported rates across racial/ethnic groups are inconsistent. Interventions may be needed to address age and racial disparities to achieve the recommended childhood influenza vaccination target of 70%. PURPOSE: To evaluate an intervention to increase childhood influenza vaccination across age and racial groups. METHODS:In 2011-2012, a total of 20 primary care practices treating children were randomly assigned to the intervention and control arms of a cluster randomized controlled trial to increase childhood influenza vaccination uptake using a toolkit and other strategies including early delivery of donated vaccine, in-service staff meetings, and publicity. RESULTS: The average vaccination differences from pre-intervention to the intervention year were significantly larger in the intervention arm (n=10 practices) than the control arm (n=10 practices); for children aged 9-18 years (11.1 pct pts intervention vs 4.3 pct pts control, p<0.05); for non-white children (16.7 pct pts intervention vs 4.6 pct pts control, p<0.001); and overall (9.9 pct pts intervention vs 4.2 pct pts control, p<0.01). In multi-level modeling that accounted for person- and practice-level variables and the interactions among age, race, and intervention, the likelihood of vaccination increased with younger age group (6-23 months); white race; commercial insurance; the practice's pre-intervention vaccination rate; and being in the intervention arm. Estimates of the interaction terms indicated that the intervention increased the likelihood of vaccination for non-white children in all age groups and white children aged 9-18 years. CONCLUSIONS: A multi-strategy intervention that includes a practice improvement toolkit can significantly improve influenza vaccination uptake across age and racial groups without targeting specific groups, especially in practices with large percentages of minority children.
RCT Entities:
BACKGROUND: Since the 2008 inception of universal childhood influenza vaccination, national rates have risen more dramatically among younger children than older children and reported rates across racial/ethnic groups are inconsistent. Interventions may be needed to address age and racial disparities to achieve the recommended childhood influenza vaccination target of 70%. PURPOSE: To evaluate an intervention to increase childhood influenza vaccination across age and racial groups. METHODS: In 2011-2012, a total of 20 primary care practices treating children were randomly assigned to the intervention and control arms of a cluster randomized controlled trial to increase childhood influenza vaccination uptake using a toolkit and other strategies including early delivery of donated vaccine, in-service staff meetings, and publicity. RESULTS: The average vaccination differences from pre-intervention to the intervention year were significantly larger in the intervention arm (n=10 practices) than the control arm (n=10 practices); for children aged 9-18 years (11.1 pct pts intervention vs 4.3 pct pts control, p<0.05); for non-white children (16.7 pct pts intervention vs 4.6 pct pts control, p<0.001); and overall (9.9 pct pts intervention vs 4.2 pct pts control, p<0.01). In multi-level modeling that accounted for person- and practice-level variables and the interactions among age, race, and intervention, the likelihood of vaccination increased with younger age group (6-23 months); white race; commercial insurance; the practice's pre-intervention vaccination rate; and being in the intervention arm. Estimates of the interaction terms indicated that the intervention increased the likelihood of vaccination for non-white children in all age groups and white children aged 9-18 years. CONCLUSIONS: A multi-strategy intervention that includes a practice improvement toolkit can significantly improve influenza vaccination uptake across age and racial groups without targeting specific groups, especially in practices with large percentages of minority children.
Authors: Melissa S Stockwell; Elyse Olshen Kharbanda; Raquel Andres Martinez; Celibell Y Vargas; David K Vawdrey; Stewin Camargo Journal: JAMA Date: 2012-04-25 Impact factor: 56.272
Authors: Anthony E Fiore; Timothy M Uyeki; Karen Broder; Lyn Finelli; Gary L Euler; James A Singleton; John K Iskander; Pascale M Wortley; David K Shay; Joseph S Bresee; Nancy J Cox Journal: MMWR Recomm Rep Date: 2010-08-06
Authors: Katherine A Poehling; Gerry Fairbrother; Yuwei Zhu; Stephanie Donauer; Sandra Ambrose; Kathryn M Edwards; Mary Allen Staat; Mila M Prill; Lyn Finelli; Norma J Allred; Barbara Bardenheier; Peter G Szilagyi Journal: Pediatrics Date: 2010-09-06 Impact factor: 7.124
Authors: Richard K Zimmerman; Alejandro Hoberman; Mary Patricia Nowalk; Chyongchiou J Lin; David P Greenberg; Stuart T Weinberg; Feng Shou Ko; Dwight E Fox Journal: Ann Fam Med Date: 2006 Nov-Dec Impact factor: 5.166
Authors: Richard K Zimmerman; Mary Patricia Nowalk; Chyongchiou J Lin; Feng Shou Ko; Bruce Block; Gregory Anderson; J Todd Wahrenberger; Dwight E Fox Journal: Vaccine Date: 2005-11-15 Impact factor: 3.641
Authors: Mary Patricia Nowalk; Jean Nutini; Mahlon Raymund; Faruque Ahmed; Steven M Albert; Richard K Zimmerman Journal: Vaccine Date: 2012-07-24 Impact factor: 3.641
Authors: Richard K Zimmerman; Mary Patricia Nowalk; Mahlon Raymund; Melissa Tabbarah; David G Hall; J Todd Wahrenberger; Stephen A Wilson; Edmund M Ricci Journal: Am J Public Health Date: 2003-10 Impact factor: 9.308
Authors: Richard K Zimmerman; Krissy K Moehling; Chyongchiou J Lin; Song Zhang; Jonathan M Raviotta; Evelyn C Reis; Sharon G Humiston; Mary Patricia Nowalk Journal: Vaccine Date: 2016-11-18 Impact factor: 3.641
Authors: Chyongchiou Jeng Lin; Mary Patricia Nowalk; Richard K Zimmerman; Krissy K Moehling; Tracey Conti; Norma J Allred; Evelyn C Reis Journal: J Pediatr Health Care Date: 2015-08-05 Impact factor: 1.812
Authors: Anna T Nguyen; Benjamin F Arnold; Chris J Kennedy; Kunal Mishra; Nolan N Pokpongkiat; Anmol Seth; Stephanie Djajadi; Kate Holbrook; Erica Pan; Pam D Kirley; Tanya Libby; Alan E Hubbard; Arthur Reingold; John M Colford; Jade Benjamin-Chung Journal: Vaccine Date: 2021-12-03 Impact factor: 3.641